Patents Assigned to MERGANSER BIOTECH, INC.
  • Hepcidin mimetic peptides and uses thereof
    Patent number: 9315545
    Abstract: Compounds and methods are described herein that can be used to treat subjects for conditions related to hepcidin activity, such as but not limited diseases of iron metabolism, beta thalassemia, hemochromatosis, iron-loading anemias, alcoholic liver disease, or chronic hepatitis C.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: April 19, 2016
    Assignee: MERGANSER BIOTECH, INC.
    Inventor: Gene Scott Merutka